http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2425671-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc7c4a963a0fcaed27b9374c2d025679
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
filingDate 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e92228cc69f22cb98acff146aca941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3464bd062811693839c8f9b01d4a65e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1e76fab2d4c647f6c12de539af48ba2
publicationDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2425671-C1
titleOfInvention Method of correcting kidney malfunction in patients with stable stenocardia in combination with hypertension
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to field of medicine, namely to cardiology, and can be used for correction of kidney dysfunction in patients with stable stenocardia in combination with hypertension. For this purpose at the background of standard therapy, which includes inhibitor of angiotensin-converting enzyme, beta-adrenoblocker, aspirin and statin, Medicaqtion ivabradin is administered in day dose 5-15 mg in 2 intakes, daily, during 6 months. n EFFECT: method makes it possible to increase efficiency of kidney malfunction correction due to positive dynamics of GFR, level of C-terminal telopeptide type I collagen and TIMP-1. n 1 tbl, 2 ex
priorityDate 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30426
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Total number of triples: 39.